Ho S C, Chiang L L, Cheng H F, Lin H C, Sheng D F, Kuo H P, Lin H C
Department of Internal Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan, R.O.C.
Chang Gung Med J. 2000 Feb;23(2):73-9.
Chronic obstructive airway diseases (COAD), characterized by mucus hypersecretion, lead to exercise intolerance. Incentive spirometry has been used to prevent postoperative pulmonary atelectasis.
To compare the efficacy of two incentive spirometers, Coach (volume-oriented) and Triflo (flow-oriented), in the work of breathing in COAD patients, 22 patients were randomized in this study: 12 patients (Triflo-II group) initially used Triflo-II for 10 minutes and then Coach for the same period. In contrast, the Coach group, including 10 patients, started with Coach followed by Triflo-II. After receiving incentive spirometry, lung expansion and work of breathing were assessed.
Patients in the Coach group significantly increased chest wall expansion (p = 0.041), as compared with patients using Triflo-II. Similarly, there was also a significantly increased abdominal wall expansion in the Coach group (p = 0.0056), compared with that in the Triflo-II group. The need of accessory muscle assistance for breathing in the Coach group was significantly less than in the Triflo-II group (p = 0.047). It was easier for patients in the Coach group to start a breath (p = 0.0058) than for those in the Triflo-II group. For the entire group, 17 patients (77.3%) preferred Coach to assist their breathing, and only 4 patients (18.2%) favored Triflo-II.
COAD patients achieved a larger expansion of the chest and abdomen with a Coach device. Our data provide a good rationale for an outcome study on the use of incentive spirometer in COAD patients.
以黏液分泌过多为特征的慢性阻塞性气道疾病(COAD)会导致运动不耐受。激励式肺量计已被用于预防术后肺不张。
为比较两种激励式肺量计,即Coach(以容量为导向)和Triflo(以流量为导向),在COAD患者呼吸过程中的效果,本研究将22例患者随机分组:12例患者(Triflo-II组)最初使用Triflo-II 10分钟,然后使用Coach同样时长。相比之下,包括10例患者的Coach组先使用Coach,然后使用Triflo-II。接受激励式肺量计训练后,评估肺扩张和呼吸功。
与使用Triflo-II的患者相比,Coach组患者的胸壁扩张显著增加(p = 0.041)。同样,与Triflo-II组相比,Coach组的腹壁扩张也显著增加(p = 0.0056)。Coach组呼吸时对辅助肌肉的需求显著低于Triflo-II组(p = 0.047)。Coach组患者开始呼吸比Triflo-II组患者更容易(p = 0.0058)。在整个组中,17例患者(77.3%)更喜欢使用Coach辅助呼吸,只有4例患者(18.2%)青睐Triflo-II。
COAD患者使用Coach设备时胸腹部扩张更大。我们的数据为关于在COAD患者中使用激励式肺量计的结果研究提供了充分的理论依据。